Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Moyamoya Disease and GUCY1A3[original query] |
---|
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance. Journal of neurosurgery 2017 Apr 126 (4): 1106-1113. Zhang Qian, Liu Yaping, Zhang Dong, Wang Rong, Zhang Yan, Wang Shuo, Yu Lanbing, Lu Chaoxia, Liu Fang, Zhou Jian, Zhang Xue, Zhao Jizo |
Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clinical genetics 2016 Jan . Wallace Stephanie, Guo Dong-Chuan, Regalado Ellen, Mellor-Crummey Lauren, Banshad Michael, Nickerson Deborah A, Dauser Robert, Hanchard Neil, Marom Ronit, Martin Emil, Berka Vladimir, Sharina Iraida, Ganesan Vijeya, Saunders Dawn, Morris Shaine, Milewicz Dianna |
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1. PloS one 2018 13 (7): e0200446. Santoro Claudia, Giugliano Teresa, Kraemer Markus, Torella Annalaura, Schwitalla Jan Claudius, Cirillo Mario, Melis Daniela, Berlit Peter, Nigro Vincenzo, Perrotta Silverio, Piluso Giul |
Higher susceptibility to heme oxidation and lower protein stability of the rare aC517Yß sGC variant associated with moyamoya syndrome. Biochemical pharmacology 2021 Feb 114459. Sharina Iraida, Lezgyieva Karina, Krutsenko Yekaterina, Martin Em |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: